MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
MiMedx (Nasdaq: MDXG) will report fourth quarter and full year 2025 operating and financial results after market close on Wednesday, February 25, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MiMedx (Nasdaq: MDXG) will report fourth quarter and full year 2025 operating and financial results after market close on Wednesday, February 25, 2026.
The senior management team will host a webcast and conference call beginning at 4:30 p.m. ET on February 25. A replay will be available on the company website for approximately 30 days.
Details
News Market Reaction – MDXG
On Feb 17, the day this news came out, MDXG closed 0.78% above the previous close.
Data tracked by StockTitan Argus for the Feb 17 session.
Key Figures
- Results period end
- December 31, 2025
- Fourth quarter and full year 2025 reporting period
- Earnings release date
- February 25, 2026
- Q4 and full year 2025 results to be reported after market close
- Call time
- 4:30 p.m. Eastern Time
- Start time for webcast and conference call
- Replay duration
- 30 days
- Webcast replay availability on company website
- U.S. dial-in
- 877-407-6184
- Conference call number for U.S. investors
- International dial-in
- 201-389-0877
- Conference call number for international investors
- Conference ID
- 13758446
- Access code for the Q4 and FY 2025 conference call
Previous Conferences,earnings Reports
-
Announced timing and access details for Q3 2025 earnings call.
-
Scheduled Q2 2025 results release and management webcast with dial-in info.
-
Outlined Q1 2025 results timing and investor access to conference call.
-
Provided schedule for Q4 and full-year 2024 earnings release and call.
-
Announced Q3 2024 reporting date and 4:30 p.m. ET webcast details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, February 25, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13758446
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.